Accipiter Biosciences, Inc. is a United States-based company founded in 2023 and headquartered in Seattle, Washington. The firm focuses on scientific research and translating biological science into new therapies.
Subscribe to see Accipiter Biosciences Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Accipiter Biosciences Inc. is a healthcare technology company headquartered in Seattle, United States. Its most recent funding round, Seed, raised $10.5M in July 2026. Xcout tracks 1 named person at Accipiter Biosciences Inc., including Matthew Bick (Chief Executive Officer).
As of 17 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $10.5M | 8 named | |
| Seed | $12.7M | 10 named | |
| SEC Form D filing | $13.6M | — | |
| SEC Form D filing | $650,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 11 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Accipiter Biosciences Inc.'s closest competitors — see the full list of competitors and alternatives →
Actio Biosciences, Inc. is a biotechnology research company headquartered in San Diego, California, United States. It leverages advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare diseases.
AltPep is a biotechnology company headquartered in Seattle, Washington. It develops innovative solutions within the biotech sector and maintains its main office on Eastlake Avenue East in Seattle. The firm employs a specialized team of professionals focused on scientific research and development.
Umoja Biopharma is a biotechnology research company headquartered in Seattle, Washington, focused on developing next-generation immunotherapies.
Outpace Bio, Inc. is a biotechnology company headquartered in Seattle, Washington, specializing in AI-powered protein design to advance cell therapies.
InduPro is a biotechnology company focused on advanced science and proximity-based therapeutics that bring cell surface proteins together for novel drug designs. The company is headquartered in Seattle, Washington.
Deverra Therapeutics, Inc. is a private biotechnology company founded in 2015 and headquartered in Seattle, Washington, focused on developing drug pipelines and therapeutic solutions.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Accipiter Biosciences Inc.? Suggest a correction · Work at Accipiter Biosciences Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.